Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sangamo Therapeutics Inc

0.5269
-0.0081-1.51%
Post-market: 0.53030.0034+0.65%16:50 EDT
Volume:1.97M
Turnover:1.05M
Market Cap:125.19M
PE:-1.40
High:0.5417
Open:0.5300
Low:0.5200
Close:0.5350
Loading ...
May 27, 2021

Major Issues Report

8-K/A [Amend] - Current report
May 04, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2021

Major Issues Report

8-K - Current report
Mar 17, 2021

Major Issues Report

8-K - Current report
Feb 24, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 24, 2021

Major Issues Report

8-K - Current report
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 28, 2021

Major Issues Report

8-K - Current report
Jan 14, 2021

Major Issues Report

8-K - Current report
Jan 06, 2021

Major Issues Report

8-K - Current report
Dec 15, 2020

Major Issues Report

8-K - Current report
Dec 07, 2020

Major Issues Report

8-K - Current report
Nov 04, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2020

Major Issues Report

8-K - Current report
Oct 15, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Sep 14, 2020

Major Issues Report

8-K - Current report
Aug 05, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans